MAGEL2与L1CAM突变与先天性垂体功能减退及关节挛缩相关
研究对5例先天性垂体功能减退(CH)合并关节挛缩患者进行分子遗传学分析,发现4例携带母源印记MAGEL2基因p.Q666fs*47杂合突变(符合Schaaf-Yang综合征),1例携带L1CAM基因p.G452R半合子变异(符合L1综合征)。人胚胎表达分析显示MAGEL2在下丘脑、腹侧间脑及Rathke囊表达,L1CAM在下丘脑、腹侧间脑及后脑表达但不表达于Rathke囊。
要点
- CH合并关节挛缩的婴幼儿应排查MAGEL2相关Schaaf-Yang综合征或L1CAM相关L1综合征。
- MAGEL2突变患者可表现生长激素缺乏及多种SHFYNG特征,部分伴尿崩症或ACTH不足。
- MAGEL2与L1CAM在下丘脑-垂体区域发育中表达,支持其与下丘脑-垂体疾病的关联。
核心结论
- MAGEL2与L1CAM突变可见于先天性垂体功能减退合并关节挛缩的家族,提示两基因与下丘脑-垂体疾病相关。
研究设计与样本
- 对5例先天性垂体功能减退合并关节挛缩患者进行分子遗传学分析及人胚胎表达分析。
主要发现
- 患者1至4携带MAGEL2基因p.Q666fs*47杂合突变,均表现生长激素缺乏及可变SHFYNG特征。
- 非identical双胞胎患者2和3伴尿崩症及大头畸形,患者4表现ACTH不足。
- 患者5携带L1CAM基因p.G452R半合子变异,表现为产前脑积水。
- 人胚胎表达分析显示MAGEL2 transcripts在CS19、20、23的下丘脑和腹侧间脑及CS20、23的Rathke囊表达。
- L1CAM在CS19、20、23的下丘脑、腹侧间脑和后脑表达,但不在Rathke囊表达。
临床怎么用
- 对生命早期出现先天性垂体功能减退合并关节挛缩的患者,应评估Schaaf-Yang综合征和/或L1综合征特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Congenital hypopituitarism (CH) is rarely observed in combination with severe joint contractures (arthrogryposis). Schaaf-Yang syndrome (SHFYNG) phenotypically overlaps with Prader-Willi syndrome, with patients also manifesting arthrogryposis. L1 syndrome, a group of X-linked disorders that include hydrocephalus and lower limb spasticity, also rarely presents with arthrogryposis. OBJECTIVE: We investigated the molecular basis underlying the combination of CH and arthrogryposis in five patients. PATIENTS: The heterozygous p.Q666fs*47 mutation in the maternally imprinted MAGEL2 gene, previously described in multiple patients with SHFYNG, was identified in patients 1 to 4, all of whom manifested growth hormone deficiency and variable SHFYNG features, including dysmorphism, developmental delay, sleep apnea, and visual problems. Nonidentical twins (patients 2 and 3) had diabetes insipidus and macrocephaly, and patient 4 presented with ACTH insufficiency. The hemizygous L1CAM variant p.G452R, previously implicated in patients with L1 syndrome, was identified in patient 5, who presented with antenatal hydrocephalus. RESULTS: Human embryonic expression analysis revealed MAGEL2 transcripts in the developing hypothalamus and ventral diencephalon at Carnegie stages (CSs) 19, 20, and 23 and in the Rathke pouch at CS20 and CS23. L1CAM was expressed in the developing hypothalamus, ventral diencephalon, and hindbrain (CS19, CS20, CS23), but not in the Rathke pouch. CONCLUSION: We report MAGEL2 and L1CAM mutations in four pedigrees with variable CH and arthrogryposis. Patients presenting early in life with this combined phenotype should be examined for features of SHFYNG and/or L1 syndrome. This study highlights the association of hypothalamo-pituitary disease with MAGEL2 and L1CAM mutations.
引用
- Gregory LC, Shah P, Sanner JRF, et al. Mutations in MAGEL2 and L1CAM Are Associated With Congenital Hypopituitarism and Arthrogryposis. J Clin Endocrinol Metab. 2019. PMID: 31504653. doi:10.1210/jc.2019-00631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。